BIOVISC ORTHO SINGLE is a medical product consisting of a sterile, transparent, uniform, viscoelastic gel that incorporates high molecular weight hyaluronic acid. This formulation comprises 90 mg per 3 ml of hyaluronic acid produced through biofermentation. It is suspended in a phosphate-buffered saline solution with an injection-grade purity level, completely devoid of animal proteins, ensuring a high-quality supplement to the synovial fluid.
The hyaluronic acid used in BIOVISC ORTHO SINGLE features a cross-linked structure, modifying its rheological characteristics to increase viscosity and decrease solubility. This modification results in a longer-lasting effect and improved compatibility within the body.
Manufactured in accordance with ISO and GMP standards, BIOVISC ORTHO SINGLE is a certified medical device.
The package includes:
- 1 pre-filled syringe with 3 ml luer lock, containing 90 mg sodium hyaluronate
Ingredients of the product:
- 90 mg/3ml (3%) of cross-linked Hyaluronic Acid obtained by bio fermentation
- Molecular Weight 3Mio.Dalton
- Average viscosity 700,000 mPa.s
- Volume 3ml
- Total concentration of Hyaluronic Acid 90 mg
The advantages of utilizing of BIOVISC ORTHO SINGLE:
- Gentle joint movement
- Decreased joint discomfort
- Enhanced lubrication and cushioning of arthritic joints
- Efficient
Product Application Guidelines:
For Biovisc Ortho, the regimen involves a series of 3-5 injections, spaced one week apart, to be repeated every six months.
Biovisc Ortho Single, on the other hand, is meant for one-time use, with injections administered once every six months.
